Navigation Links
Should doctors tell patients about expensive, unfunded drugs?

It is unethical and paternalistic for doctors to withhold information from patients about new drugs that are not yet publicly funded, say researchers in this week's BMJ.

New drugs may be more effective than existing treatments, but many are very expensive and may not be available through publicly funded health schemes.

This raises several ethical dilemmas for doctors. Is it reasonable to ask a patient to finance the full cost of their treatment when it is not provided by government? Would it be unethical to raise the option of treatment with an unsubsidised drug?

Researchers surveyed 184 Australian cancer specialists about their opinions and practices regarding potentially useful but unsubsidised drugs.

A large proportion said they would not discuss an expensive drug with a patient if it were not subsidised because of potential psychological and emotional effects that these discussions might have on patients and their families. The survey also found that these discussions were stressful for clinicians.

But the authors argue that this practice fails to respect autonomy and may not be in the patient's best interests. They believe that withholding information on the basis of what a patient would want is "a dangerous medical path to unjustified paternalism."

A further ethical issue concerns the cost of publicly funding newer, expensive treatments, they write. This is an urgent question of distributing limited resources fairly that faces not just new drugs, but many forms of modern technological care. "The gap between what we can do and what we can afford will continue to grow, at a personal and community level."

The issue of accessing new expensive drugs has no easy solution, they say. Nevertheless, it seems unreasonable to withhold information from a patient about any potentially beneficial treatment because of concerns about capacity to pay, even if these discussions cause distress for some patients.

Society at large should discuss whether new, high-cost drugs should be publicly funded, they conclude.


'"/>

Source:BMJ-British Medical Journal


Related biology news :

1. Survey reveals women and doctors arent talking about HPV
2. Efficiency, not more doctors, is the prescription for aging population
3. Stanford doctors advance in bid to turn mice stem cells into blood vessels
4. Patients and their doctors have different perceptions about HIV and its treatment
5. Free drug samples influence prescribing, say one in three doctors
6. Reminding doctors which antibiotics to prescribe cuts C. difficile infection rates
7. Genes and biomarkers that allow doctors to choose the right therapy for the right patient
8. Study identifies predictors of HIV drug resistance in patients beginning triple therapy
9. Potential Cure for Lymphoma in HIV patients
10. Ophthalmologists implant five patients with artificial silicon retina microchip
11. Technique may allow cancer patients to freeze eggs, preserving fertility before starting treatment
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/17/2017)... , April 17, 2017 NXT-ID, Inc. ... company, announces the filing of its 2016 Annual Report on Form ... Exchange Commission. ... Form 10-K is available in the Investor Relations section of the ... on the SEC,s website at http://www.sec.gov . 2016 ...
(Date:4/11/2017)... , April 11, 2017 No ... but researchers at the New York University Tandon ... of Engineering have found that partial similarities between ... systems used in mobile phones and other electronic ... The vulnerability lies in the fact ...
(Date:4/5/2017)... , April 4, 2017 KEY FINDINGS ... anticipated to expand at a CAGR of 25.76% during ... diseases is the primary factor for the growth of ... report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global ... product, technology, application, and geography. The stem cell market ...
Breaking Biology News(10 mins):
(Date:8/15/2017)... ... August 15, 2017 , ... JULABO USA introduces its new ... website makes it easy to navigate through the site whether you’re in the ... product information, educational industry content and visit the company’s social media accounts, all ...
(Date:8/11/2017)... , Aug. 11, 2017  Market ... New York Times article regarding the telemedicine ... according to Kalorama Information.  The article, ... for That"  used information from Kalorama ... Monitoring & Telemedicine Market  (Sleep, Diabetes, ...
(Date:8/10/2017)... ... August 09, 2017 , ... As ... industry reach its ideal customers with the right message. Their effective, cutting-edge inbound ... Midwest company, we realize how crucial the agriculture industry is,” said David Phelps, ...
(Date:8/10/2017)... (PRWEB) , ... August 09, 2017 , ... Okyanos Center ... take place at the Pelican Bay Hotel in Freeport, Grand Bahama on September 27, ... is required. , With oversight from the Ministry of Health’s National Stem Cell ...
Breaking Biology Technology: